Skip to content

Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders

Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders With Adults: Manual Development and Randomized-Controled Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02360033
Enrollment
38
Registered
2015-02-10
Start date
2015-01-31
Completion date
2017-09-30
Last updated
2019-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Anxiety Disorder

Brief summary

Goals of the study: Systemic Therapy was approved in 2008 by the Scientific Advisory Board on Psychotherapy (Wissenschaftlicher Beirat Psychotherapie: WBP) for a variety of disorders which, at the time, did not include anxiety disorders. According to the 2007 joint methods paper of the WBP and the Mutual Federal Committee (Gemeinsamen Bundesausschuss: G-Ba), there must be three randomized-controlled trials (RCT) for anxiety disorders. These studies are available now but lack explicit details about the clinical significance of the reductions they show in social anxiety symptoms. This project is funded by the German Association for Systemic Therapy, Counseling and Family Therapy (Deutsche Gesellschaft für Systemische Therapie, Beratung und Familientherapie: DGSF). Study design: The study is planned as a mono-centric, balanced pilot RCT. It investigates the feasibility of an RCT comparing Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders (SAD) in 32 patients.

Interventions

BEHAVIORALSystemic Therapy for Social Anxiety Disorder

Sponsors

German Association for Systemic Therapy, Counseling and Family Therapy (DGSF)
CollaboratorUNKNOWN
Systemic Society (SG)
CollaboratorUNKNOWN
Heidehof Foundation
CollaboratorUNKNOWN
Heidelberg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Social Anxiety Disorder (SKID: ICD-Diagnosis: F40.1, Liebowitz Social Anxiety Scale \> 30); * Agreement to participate in the study and to be randomized into the two treatment groups

Exclusion criteria

* Acute drug or alcohol intoxication or dependency * Anorexia with BMI \< 14 * Psychotic disorder * Severe physical diseases

Design outcomes

Primary

MeasureTime frameDescription
Change of Liebowitz Social Anxiety Scale (LSAS-SR)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationSocial Anxiety will be assessed using the Liebowitz Social Anxiety Scale (LSAS-SR) in its German version. The LSAS-SR is a brief 24-item self report instrument with 13 items relating to performance anxiety and 11 concerning social situations. Its purpose is to assess the range of social interaction and performance situations feared and the degree of avoidance by a patient in order to assist in the diagnosis of social anxiety disorder, 24 items, German version
Change of Social Interaction Anxiety Scale (SIAS)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationMeasure of social interaction anxiety, 20 items, German version
Change of Social Phobia Scale (SPS)Baseline, 8th,15th and 20th hour of therapy, end of treatment; 6, 9 and 12 months after randomizationMeasure of anxiety while being observed by others, 20 items, German version

Secondary

MeasureTime frameDescription
Change of Experience in Social Systems (EXIS)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationMeasure of the individual experience in different social systems, 24 items, German version
Change of Beck Depression Inventory-II (BDI-II)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationSeverity of depressive symptoms at that moment, specifically assessing the intensity of depression in psychiatric and normal populations, 21 items, German version
Change of Inventory of Interpersonal Problems (IIP-32)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationThe IIP-32 is a self-report instrument that identifies a person's most salient interpersonal difficulties. It is a short version of the Inventory of Interpersonal Problems, 32 items, German version
Change of Adjustment to Symptomatology Scale (ASS)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationMeasure of adjustment to the symptomatology, 5 items, German version
Change of University of Rhode Island Change Assessment (URICA-S, short version)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationMeasure of stages of change, 16 items, German version
Change of Burden Assessment Scale (BAS)Baseline, 26th hour of therapy; 12 months after randomizationMeasure of perceived burden in daily life among resource persons, 19 items, German version
Change of Scale for the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (SACiP),8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationMeasure of the six dimensions of resource activation, problem actuation, mastery, clarification of meaning, emotional bond, agreement on collaboration, 21 items, German version
Change of Dyadic Adjustment Scale (DAS-12)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationMeasure of relationship adjustment, 12 items, German version
Change of Evaluation of Social Systems (EVOS)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationMeasure of social relationships in different social systems, 10 items, German version
Change of Brief Symptom Checklist (BSCL)Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomizationThe instrument provides an overview of a patient's symptoms and their intensity at a specific point in time, 53 items, German version

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026